BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 10706860)

  • 1. Non-MALT marginal zone B-cell lymphomas: a description of clinical presentation and outcome in 124 patients.
    Berger F; Felman P; Thieblemont C; Pradier T; Baseggio L; Bryon PA; Salles G; Callet-Bauchu E; Coiffier B
    Blood; 2000 Mar; 95(6):1950-6. PubMed ID: 10706860
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Primary nodal marginal zone lymphomas of splenic and MALT type.
    Campo E; Miquel R; Krenacs L; Sorbara L; Raffeld M; Jaffe ES
    Am J Surg Pathol; 1999 Jan; 23(1):59-68. PubMed ID: 9888704
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nodal monocytoid B-cell lymphoma (nodal marginal-zone B-cell lymphoma).
    Nathwani BN; Drachenberg MR; Hernandez AM; Levine AM; Sheibani K
    Semin Hematol; 1999 Apr; 36(2):128-38. PubMed ID: 10319381
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Marginal zone B-cell lymphoma: A clinical comparison of nodal and mucosa-associated lymphoid tissue types. Non-Hodgkin's Lymphoma Classification Project.
    Nathwani BN; Anderson JR; Armitage JO; Cavalli F; Diebold J; Drachenberg MR; Harris NL; MacLennan KA; Müller-Hermelink HK; Ullrich FA; Weisenburger DD
    J Clin Oncol; 1999 Aug; 17(8):2486-92. PubMed ID: 10561313
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Marginal zone lymphomas: extranodal MALT type, nodal and splenic].
    Dallenbach FE; Coupland SE; Stein H
    Pathologe; 2000 Mar; 21(2):162-77. PubMed ID: 10840821
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical implications of nodal marginal zone B-cell lymphoma among Japanese: study of 65 cases.
    Kojima M; Inagaki H; Motoori T; Itoh H; Shimizu K; Tamaki Y; Murase T; Nakamura S
    Cancer Sci; 2007 Jan; 98(1):44-9. PubMed ID: 17052258
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diffuse low-grade B-cell lymphomas. Four clinically distinct subtypes defined by a combination of morphologic and immunophenotypic features.
    Zukerberg LR; Medeiros LJ; Ferry JA; Harris NL
    Am J Clin Pathol; 1993 Oct; 100(4):373-85. PubMed ID: 8213632
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical presentation and management of marginal zone lymphomas.
    Thieblemont C
    Hematology Am Soc Hematol Educ Program; 2005; ():307-13. PubMed ID: 16304396
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Marginal zone B-cell lymphomas including mucosa-associated lymphoid tissue type lymphoma (MALT), monocytoid B-cell lymphoma and splenic marginal zone cell lymphoma and their relation to the reactive marginal zone.
    de Wolf-Peeters C; Pittaluga S; Dierlamm J; Wlodarska I; Van Den Berghe H
    Leuk Lymphoma; 1997 Aug; 26(5-6):467-78. PubMed ID: 9389354
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Splenic and nodal marginal zone lymphomas are indolent disorders at high hepatitis C virus seroprevalence with distinct presenting features but similar morphologic and phenotypic profiles.
    Arcaini L; Paulli M; Boveri E; Vallisa D; Bernuzzi P; Orlandi E; Incardona P; Brusamolino E; Passamonti F; Burcheri S; Schena C; Pascutto C; Cavanna L; Magrini U; Lazzarino M
    Cancer; 2004 Jan; 100(1):107-15. PubMed ID: 14692030
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcome and prognostic factors in ocular adnexal lymphoma.
    Nola M; Lukenda A; Bollmann M; Kalauz M; Petrovecki M; Bollmann R
    Croat Med J; 2004 Jun; 45(3):328-32. PubMed ID: 15185428
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Subcutaneous 'lipoma-like' B-cell lymphoma associated with HCV infection: a new presentation of primary extranodal marginal zone B-cell lymphoma of MALT.
    Paulli M; Arcaini L; Lucioni M; Boveri E; Capello D; Passamonti F; Merli M; Rattotti S; Rossi D; Riboni R; Berti E; Magrini U; Bruno R; Gaidano G; Lazzarino M
    Ann Oncol; 2010 Jun; 21(6):1189-1195. PubMed ID: 19858084
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-MALT marginal zone lymphoma.
    Thieblemont C; Davi F; Noguera ME; Brière J
    Curr Opin Hematol; 2011 Jul; 18(4):273-9. PubMed ID: 21577105
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Leukaemic subtype of marginal zone lymphoma: a presentation of three cases and literature review.
    Tam CS; Prince HM; Westerman D; Seymour JF; Juneja S
    Leuk Lymphoma; 2004 Apr; 45(4):705-10. PubMed ID: 15160943
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Marginal zone-related neoplasms of splenic and nodal origin.
    Arcaini L; Paulli M; Boveri E; Magrini U; Lazzarino M
    Haematologica; 2003 Jan; 88(1):80-93. PubMed ID: 12551831
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MALT Lymphomas.
    Cavalli F; Isaacson PG; Gascoyne RD; Zucca E
    Hematology Am Soc Hematol Educ Program; 2001; ():241-58. PubMed ID: 11722987
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-dose therapy and autologous stem cell transplantation in marginal zone lymphomas: a retrospective study by the EBMT Lymphoma Working Party and FIL-GITMO.
    Avivi I; Arcaini L; Ferretti VV; Boumendil A; Finel H; Milone G; Zaja F; Liliana D; Musso M; Didier B; Bachy E; Wattad M; Nicolas-Virelizier E; Gramatzki M; Bourhis JH; Caillot D; Haenel A; Held G; Thieblemont C; Jindra P; Pohlreich D; Guilhot F; Kroschinsky F; Wahlin B; Scheid C; Ifrah N; Berthou C; Dreger P; Montoto S; Conconi A
    Br J Haematol; 2018 Sep; 182(6):807-815. PubMed ID: 29984825
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Purine analogs in marginal-zone lymphomas.
    Horning SJ
    Ann Oncol; 1996; 7 Suppl 6():S21-6. PubMed ID: 9010575
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Marginal zone lymphomas: management of nodal, splenic, and MALT NHL.
    Kahl B; Yang D
    Hematology Am Soc Hematol Educ Program; 2008; ():359-64. PubMed ID: 19074110
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of marginal zone lymphomas.
    Thieblemont C; Coiffier B
    Curr Treat Options Oncol; 2006 May; 7(3):213-22. PubMed ID: 16615877
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.